Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
It may also help to boost compliance when injectables are not preferred and could be priced lower to reach a broader swathe of patients, especially outside the United States. Morgan Stanley: A broader and more lasting behavioral shift According to recent research from Morgan Stanley, its biopharma analysts expect the US anti-obesity medication (AOM) patient pool to increase fivefold to 24 million people (7% of the US population) over the next decade
See our how to get retatrutide guide for the full FDA timeline, clinical trial enrollment steps, and what alternatives are available now
Understanding these differences helps clarify what to expect from each approach and why treatment timelines vary
The cost of tirzepatide represents a significant consideration for patients and healthcare systems, as no generic alternative currently exists to provide price competition
Lee JH, Wen X, Cho H, Koo SH
US$ 21.46
US$ 24.69
US$ 23.99
US$ 29.48
US$ 21.24
